(Q37855988)

24 August 2017

1 reference

title

Uremic toxins and oral adsorbents (English)

1 reference

24 August 2017

Shunsuke Goto

1

1 reference

24 August 2017

Kunihiko Yoshiya

2

1 reference

24 August 2017

Tomoyuki Kita

3

1 reference

24 August 2017

Hideki Fujii

4

1 reference

24 August 2017

Masafumi Fukagawa

5

1 reference

24 August 2017

8 March 2011

1 reference

Therapeutic Apheresis and Dialysis

24 August 2017

1 reference

24 August 2017

15

1 reference

24 August 2017

132-134

1 reference

24 August 2017

2

1 reference

Review on uremic toxins: classification, concentration, and interindividual variability

24 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00891.X

A bench to bedside view of uremic toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00891.X

Uremic toxins originating from colonic microbial metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00891.X

Effect of a carbonaceous oral adsorbent on the progression of CKD: a multicenter, randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00891.X

Oral ADSORBENT AST-120 decreases carotid intima-media thickness and arterial stiffness in patients with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00891.X

Oral charcoal adsorbent (AST-120) prevents progression of cardiac damage in chronic kidney disease through suppression of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00891.X

Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00891.X

Administration of oral charcoal adsorbent (AST-120) suppresses low-turnover bone progression in uraemic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00891.X

Association between indoxyl sulfate and skeletal resistance in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00891.X

Bile acid binding to sevelamer HCl.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00891.X

Determinants of progressive vascular calcification in haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00891.X

A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00891.X

Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00891.X

Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00891.X

10.1111/J.1744-9987.2010.00891.X

21 January 2018

Identifiers

DOI

1 reference

release_5zu4ko5jkrc53oatqnygwjgbla

24 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5zu4ko5jkrc53oatqnygwjgbla

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference